Rocket Pharmaceuticals, Inc.(RCKT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RCKT Rocket Pharmaceuticals, Inc.

休市中 07-11 16:00:00 EDT

2.96

-0.20

-6.33%

盘后3.05

+0.09+3.04%

19:51 EDT

最高3.14	最低2.95	成交量171.05万
今开3.12	昨收3.16	日振幅6.01%
总市值3.19亿	流通市值2.41亿	总股本1.08亿
成交额518.06万	换手率2.10%	流通股本8,146万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RCKT","market":"US","secType":"STK","nameCN":"Rocket Pharmaceuticals, Inc.","latestPrice":2.96,"timestamp":1752264000000,"preClose":3.16,"halted":0,"volume":1710519,"hourTrading":{"tag":"盘后","latestPrice":3.05,"preClose":2.96,"latestTime":"19:51 EDT","volume":35091,"amount":103810.9203,"timestamp":1752277862984},"delay":0,"floatShares":81461922,"shares":107737919,"eps":-2.607807,"marketStatus":"休市中","change":-0.2,"latestTime":"07-11 16:00:00 EDT","open":3.115,"high":3.14,"low":2.95,"amount":5180566.790388,"amplitude":0.060127,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.607807,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1424235600000,"exchange":"NASDAQ","adjPreClose":3.16,"preHourTrading":{"tag":"盘前","latestPrice":3.14,"preClose":3.16,"latestTime":"09:29 EDT","volume":4026,"amount":12626.5280064,"timestamp":1752240589019},"postHourTrading":{"tag":"盘后","latestPrice":3.05,"preClose":2.96,"latestTime":"19:51 EDT","volume":35091,"amount":103810.9203,"timestamp":1752277862984},"volumeRatio":0.646604,"impliedVol":0.4943,"impliedVolPercentile":0.12},"requestUrl":"/m/hq/s/RCKT","defaultTab":"news","newsList":[{"id":"2550659932","title":"Rocket Pharmaceuticals, Inc.盘中异动 大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550659932?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:58","pubTimestamp":1752073118,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时58分，Rocket Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.00%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。其相关个股中，Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为1161.25%、714.98%、534.59%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Prokidney Corp.，振幅分别为173.13%、112.02%、64.08%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225838979fc9a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225838979fc9a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2548883342","title":"Rocket Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548883342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548883342?lang=zh_cn&edition=full","pubTime":"2025-07-01 23:19","pubTimestamp":1751383169,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时19分，Rocket Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.25%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Neurogene Inc.、Atai Life Sciences N.V.涨幅较大，Oragenics Inc.、Soligenix, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1863.65%、1379.07%、194.22%，振幅较大的相关个股有Lixte Biotechnology Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Soligenix, Inc.，振幅分别为69.61%、55.78%、43.51%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012319299532b6ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012319299532b6ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2546326245","title":"Rocket Pharmaceuticals, Inc.6月24日成交额为1107.71万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546326245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546326245?lang=zh_cn&edition=full","pubTime":"2025-06-25 13:15","pubTimestamp":1750828540,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，Rocket Pharmaceuticals, Inc.成交额为1107.71万美元，成交额较昨日增加26.72%，当日成交量为400.82万股。Rocket Pharmaceuticals, Inc.于2025年6月24日涨5.32%，报2.77美元，该股过去5个交易日跌3.82%，年初至今跌77.96%，过去60日跌64.85%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-24|1107.71万|26.72%|400.82万|#|2025-06-23|874.17万|-55.65%|331.12万|#|2025-06-20|1971.28万|54.29%|723.32万|#|2025-06-18|1277.67万|8.24%|450.28万|#|2025-06-17|1180.40万|1.54%|424.13万|Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625131543a71c6190&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625131543a71c6190&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2545471788","title":"Rocket Pharmaceuticals, Inc.6月23日成交额为874.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545471788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545471788?lang=zh_cn&edition=full","pubTime":"2025-06-24 13:14","pubTimestamp":1750742069,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日，Rocket Pharmaceuticals, Inc.成交额为874.17万美元，成交额较昨日减少55.65%，当日成交量为331.12万股。Rocket Pharmaceuticals, Inc.于2025年6月23日跌2.59%，报2.63美元，该股过去5个交易日跌10.24%，年初至今跌79.08%，过去60日跌65.8%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-23|874.17万|-55.65%|331.12万|#|2025-06-20|1971.28万|54.29%|723.32万|#|2025-06-18|1277.67万|8.24%|450.28万|#|2025-06-17|1180.40万|1.54%|424.13万|#|2025-06-16|1162.45万|25.89%|404.31万|Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624131431a71a9658&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624131431a71a9658&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2544545993","title":"瑞银：维持Rocket Pharmaceuticals(RCKT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至5.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544545993","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544545993?lang=zh_cn&edition=full","pubTime":"2025-06-17 21:50","pubTimestamp":1750168220,"startTime":"0","endTime":"0","summary":"瑞银：维持Rocket Pharmaceuticals(RCKT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至5.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/17215051129250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RCKT"],"gpt_icon":0},{"id":"2543657706","title":"Rocket Pharmaceuticals, Inc.6月13日成交额为923.41万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543657706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543657706?lang=zh_cn&edition=full","pubTime":"2025-06-14 12:43","pubTimestamp":1749876238,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日，Rocket Pharmaceuticals, Inc.成交额为923.41万美元，成交额较昨日减少8.52%，当日成交量为310.82万股。Rocket Pharmaceuticals, Inc.于2025年6月13日跌4.56%，报2.93美元，该股过去5个交易日跌4.56%，年初至今跌76.69%，过去60日跌65.37%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-13|923.41万|-8.52%|310.82万|#|2025-06-12|1009.39万|-28.43%|328.71万|#|2025-06-11|1410.40万|17.72%|443.30万|#|2025-06-10|1198.06万|-17.47%|379.14万|#|2025-06-09|1451.74万|-16.83%|477.81万|Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614124404a4a8afbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614124404a4a8afbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2542661755","title":"Rocket Pharmaceuticals, Inc.6月11日成交额为1410.40万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542661755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542661755?lang=zh_cn&edition=full","pubTime":"2025-06-12 12:31","pubTimestamp":1749702666,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日，Rocket Pharmaceuticals, Inc.成交额为1410.40万美元，成交额较昨日增加17.72%，当日成交量为443.30万股。Rocket Pharmaceuticals, Inc.于2025年6月11日跌4.11%，报3.03美元，该股过去5个交易日涨3.77%，年初至今跌75.89%，过去60日跌65.69%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-11|1410.40万|17.72%|443.30万|#|2025-06-10|1198.06万|-17.47%|379.14万|#|2025-06-09|1451.74万|-16.83%|477.81万|#|2025-06-06|1745.55万|24.71%|572.25万|#|2025-06-05|1399.73万|1.97%|498.47万|Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612123110a7049145&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612123110a7049145&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2542376272","title":"Rocket Pharmaceuticals, Inc.6月10日成交额为1198.06万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542376272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542376272?lang=zh_cn&edition=full","pubTime":"2025-06-11 12:10","pubTimestamp":1749615025,"startTime":"0","endTime":"0","summary":"美东时间2025年6月10日，Rocket Pharmaceuticals, Inc.成交额为1198.06万美元，成交额较昨日减少17.47%，当日成交量为379.14万股。Rocket Pharmaceuticals, Inc.于2025年6月10日涨4.64%，报3.16美元，该股过去5个交易日涨6.76%，年初至今跌74.86%，过去60日跌63.93%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-10|1198.06万|-17.47%|379.14万|#|2025-06-09|1451.74万|-16.83%|477.81万|#|2025-06-06|1745.55万|24.71%|572.25万|#|2025-06-05|1399.73万|1.97%|498.47万|#|2025-06-04|1372.63万|-40.59%|461.12万|Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611121029a7030fed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611121029a7030fed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2542380202","title":"Rocket Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542380202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542380202?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:35","pubTimestamp":1749476125,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时35分，Rocket Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.28%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Synaptogenix, Inc.涨幅较大，Pmgc Holdings Inc.、Klotho Neurosciences, Inc.、Synaptogenix, Inc.较为活跃，换手率分别为1059.81%、970.34%、645.99%，振幅较大的相关个股有Metsera, Inc.、Tenaya Therapeutics, Inc.、Polyrizon Ltd.，振幅分别为128.01%、117.86%、110.70%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213525a4a07bc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213525a4a07bc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2541884907","title":"Rocket Pharmaceuticals, Inc.6月5日成交额为1399.73万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541884907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541884907?lang=zh_cn&edition=full","pubTime":"2025-06-06 12:15","pubTimestamp":1749183357,"startTime":"0","endTime":"0","summary":"美东时间2025年6月5日，Rocket Pharmaceuticals, Inc.成交额为1399.73万美元，成交额较昨日增加1.97%，当日成交量为498.47万股。Rocket Pharmaceuticals, Inc.于2025年6月5日跌5.14%，报2.77美元，该股过去5个交易日涨5.73%，年初至今跌77.96%，过去60日跌66.26%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-05|1399.73万|1.97%|498.47万|#|2025-06-04|1372.63万|-40.59%|461.12万|#|2025-06-03|2310.61万|-2.56%|783.11万|#|2025-06-02|2371.36万|27.88%|863.49万|#|2025-05-30|1854.42万|-28.57%|743.48万|Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606121607a6fca9a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606121607a6fca9a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2541017242","title":"Rocket Pharmaceuticals, Inc.6月4日成交额为1372.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541017242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541017242?lang=zh_cn&edition=full","pubTime":"2025-06-05 12:08","pubTimestamp":1749096538,"startTime":"0","endTime":"0","summary":"美东时间2025年6月4日，Rocket Pharmaceuticals, Inc.成交额为1372.63万美元，成交额较昨日减少40.59%，当日成交量为461.12万股。Rocket Pharmaceuticals, Inc.于2025年6月4日跌1.35%，报2.92美元，该股过去5个交易日涨17.74%，年初至今跌76.77%，过去60日跌66.01%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-04|1372.63万|-40.59%|461.12万|#|2025-06-03|2310.61万|-2.56%|783.11万|#|2025-06-02|2371.36万|27.88%|863.49万|#|2025-05-30|1854.42万|-28.57%|743.48万|#|2025-05-29|2596.04万|-49.91%|1005.66万|Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605120908a49acd4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605120908a49acd4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2540777208","title":"Rocket Pharmaceuticals, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540777208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540777208?lang=zh_cn&edition=full","pubTime":"2025-06-03 22:00","pubTimestamp":1748959255,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日22时00分，Rocket Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.05%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Traws Pharma, Inc.、Lyra Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Revelation Biosciences, Inc.、Traws Pharma, Inc.、Nucana Plc较为活跃，换手率分别为3671.42%、924.03%、750.86%，振幅较大的相关个股有Oragenics Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 、Renovaro Inc.，振幅分别为51.50%、38.06%、37.81%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603220055a498678f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603220055a498678f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2540796844","title":"Rocket Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.18%报2.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540796844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540796844?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:33","pubTimestamp":1748871199,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时33分，Rocket Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.18%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Lyra Therapeutics, Inc.、Oragenics Inc.、Vera Therapeutics, Inc.涨幅较大，Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为983.56%、586.17%、261.74%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Oragenics Inc.、Nutriband Inc C/Wts ，振幅分别为72.82%、57.67%、41.96%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213320950b947e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213320950b947e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2539278569","title":"Rocket Pharmaceuticals, Inc.盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539278569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539278569?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:32","pubTimestamp":1748611933,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日21时32分，Rocket Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.31%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为3.31%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。该信息摘要如下：加拿大蒙特利尔银行：维持Rocket Pharmaceuticals评级，由优于大市调整至优于大市评级, 目标价由30.00美元调整至8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213213a6f36ece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213213a6f36ece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2539871352","title":"Rocket Pharmaceuticals, Inc.5月28日成交额为5182.89万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539871352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539871352?lang=zh_cn&edition=full","pubTime":"2025-05-29 12:02","pubTimestamp":1748491334,"startTime":"0","endTime":"0","summary":"美东时间2025年5月28日，Rocket Pharmaceuticals, Inc.成交额为5182.89万美元，成交额较昨日减少61.36%，当日成交量为2095.08万股。Rocket Pharmaceuticals, Inc.于2025年5月28日涨6.44%，报2.48美元，该股过去5个交易日跌63.8%，年初至今跌80.27%，过去60日跌71.79%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-28|5182.89万|-61.36%|2095.08万|#|2025-05-27|1.34亿|931.93%|5476.73万|#|2025-05-23|1299.71万|-10.97%|208.10万|#|2025-05-22|1459.93万|-11.21%|220.34万|#|2025-05-21|1644.18万|-0.52%|248.72万|Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529120223a6f13ec9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529120223a6f13ec9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2538475779","title":"Chardan Capital：维持Rocket Pharmaceuticals(RCKT.US)评级，由买入调整至买入评级, 目标价由46.00美元调整至17.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2538475779","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538475779?lang=zh_cn&edition=full","pubTime":"2025-05-28 20:26","pubTimestamp":1748435211,"startTime":"0","endTime":"0","summary":"Chardan Capital：维持Rocket Pharmaceuticals(RCKT.US)评级，由买入调整至买入评级, 目标价由46.00美元调整至17.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/28202650723134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RCKT"],"gpt_icon":0},{"id":"2538467455","title":"丹农病基因治疗研究中一名临床试验参与者死亡，该研究由火箭制药公司进行Clinical Trial Participant Dies During Rocket Pharmaceuticals Gene Therapy Study for Danon Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2538467455","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538467455?lang=zh_cn&edition=full","pubTime":"2025-05-27 22:13","pubTimestamp":1748355180,"startTime":"0","endTime":"0","summary":"Rocket Pharmaceuticals disclosed the death but did not provide specific details regarding the circumstances surrounding it or whether it was directly related to the experimental treatment. Danon disease is known for its severe impact on cardiac function, often leading to life-threatening complications.Rocket Pharmaceuticals 披露了这起死亡事件，但未提供有关其具体情况或是否与实验性治疗直接相关的细节。随着对这一事件调查的继续，预计火箭制药公司将提供更多更新。Generic Drug Developers Urged to Prioritize Pharmacovigilance Amidst Concerns Over Medication Errors Causing 400,000 U.S. Deaths Annually仿制药开发商被敦促优先重视药物警戒，此前有担忧称用药错误每年导致美国40万人死亡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052722171195046e1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052722171195046e1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":1},{"id":"2538464079","title":"Rocket Pharmaceuticals, Inc.股价重挫62.92% 市值跌1.57亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538464079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538464079?lang=zh_cn&edition=full","pubTime":"2025-05-27 21:30","pubTimestamp":1748352604,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日21时30分，Rocket Pharmaceuticals, Inc.股票出现异动，股价快速下挫62.92%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.涨幅较大，Nucana Plc、Bioxcel Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为197.28%、73.47%、68.03%，振幅较大的相关个股有Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.，振幅分别为0.00%、0.00%、0.00%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052721300497673e00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052721300497673e00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2537156920","title":"Rocket Pharmaceuticals, Inc.盘中异动 下午盘大幅下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537156920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537156920?lang=zh_cn&edition=full","pubTime":"2025-05-24 01:10","pubTimestamp":1748020255,"startTime":"0","endTime":"0","summary":"北京时间2025年05月24日01时10分，Rocket Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.03%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Imunon, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Polyrizon Ltd.、Imunon, Inc.、Nucana Plc较为活跃，换手率分别为4154.72%、2240.71%、1068.83%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Imunon, Inc.，振幅分别为208.33%、170.40%、101.08%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524011055aa2c9898&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524011055aa2c9898&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2537487647","title":"Rocket Pharmaceuticals, Inc.盘中异动 下午盘急速上涨5.12%报6.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537487647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537487647?lang=zh_cn&edition=full","pubTime":"2025-05-21 02:06","pubTimestamp":1747764400,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日02时06分，Rocket Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.12%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Eyenovia, Inc.涨幅较大，Polyrizon Ltd.、Eyenovia, Inc.、Neuraxis, Inc.较为活跃，换手率分别为5079.84%、1627.58%、1151.16%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为174.55%、111.89%、104.35%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052102064094fcf3e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052102064094fcf3e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rocketpharma.com","stockEarnings":[{"period":"1week","weight":0.0207},{"period":"1month","weight":-0.0231},{"period":"3month","weight":-0.4383},{"period":"6month","weight":-0.7343},{"period":"1year","weight":-0.8652},{"period":"ytd","weight":-0.7645}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rocket Pharmaceuticals, Inc.于1999年7月7日根据特拉华州法律注册成立。该公司是一家完全整合的、处于后期阶段的生物技术公司，专注于开发首创、唯一和同类最佳的基因疗法，具有直接的靶向作用机制和明确的临床终点，用于罕见和破坏性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.066269},{"month":2,"riseRate":0.4,"avgChangeRate":-0.021166},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.066486},{"month":4,"riseRate":0.636364,"avgChangeRate":0.013738},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.036361},{"month":6,"riseRate":0.545455,"avgChangeRate":-0.005129},{"month":7,"riseRate":0.636364,"avgChangeRate":0.135432},{"month":8,"riseRate":0.4,"avgChangeRate":-0.038018},{"month":9,"riseRate":0.6,"avgChangeRate":0.104123},{"month":10,"riseRate":0.5,"avgChangeRate":0.037428},{"month":11,"riseRate":0.6,"avgChangeRate":0.025415},{"month":12,"riseRate":0.5,"avgChangeRate":0.110136}],"exchange":"NASDAQ","name":"Rocket Pharmaceuticals, Inc.","nameEN":"Rocket Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rocket Pharmaceuticals, Inc.(RCKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rocket Pharmaceuticals, Inc.(RCKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rocket Pharmaceuticals, Inc.,RCKT,Rocket Pharmaceuticals, Inc.股票,Rocket Pharmaceuticals, Inc.股票老虎,Rocket Pharmaceuticals, Inc.股票老虎国际,Rocket Pharmaceuticals, Inc.行情,Rocket Pharmaceuticals, Inc.股票行情,Rocket Pharmaceuticals, Inc.股价,Rocket Pharmaceuticals, Inc.股市,Rocket Pharmaceuticals, Inc.股票价格,Rocket Pharmaceuticals, Inc.股票交易,Rocket Pharmaceuticals, Inc.股票购买,Rocket Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rocket Pharmaceuticals, Inc.(RCKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rocket Pharmaceuticals, Inc.(RCKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}